Sinovac nabs Chinese vaccine tenders for hep A, influenza

It's a good week to be Sinovac, which has won a pair of vaccine tenders in China. On Monday, the company announced that the Beijing Health Bureau had declared it the sole supplier of inactivated hepatitis A vaccine to its Expanded Program of Immunization--a tender worth about 16 million RMB ($2.6 million). And on Wednesday, Beijing's Centers for Disease Control and Prevention selected it as a supplier of seasonal flu vaccines. Release | Release